ISIN | CH0506063285 |
---|---|
Valorennummer | 50606328 |
Bloomberg Global ID | |
Fondsname | UBAM (CH) - Swiss Equity (CHF) U |
Fondsanbieter |
Union Bancaire Privée, UBP SA
Genève 1, Schweiz Telefon: +41 22 819 28 00 E-Mail: ubpfunds@ubp.com Web: www.ubp.com |
Fondsanbieter | Union Bancaire Privée, UBP SA |
Vertreter in der Schweiz | |
Distributor(en) |
Banque Cantonale Vaudoise Lausanne Telefon: +41 21 212 10 00 |
Anlagekategorie | Aktienfonds |
EFC-Kategorie | |
Anteilskategorie | Distribution |
Domizilland | Schweiz |
Konditionen bei der Ausgabe | keine Ausgabekommission und/oder Gebühren zugunsten des Fonds (Ausgabe erfolgt zum Inventarwert) |
Konditionen bei der Rücknahme | Keine Rücknahmekommission und/oder Gebühren zugunsten des Fonds (Rücknahme erfolgt zum Inventarwert) |
Investment-Strategie *** | The Swiss Equity sub-fund aims in the medium term, to generate superior returns relative to the Swiss equity market as measured by the SPI® index. The sub-fund is actively managed and the companies are chosen after a rigorous and diverse selection process. No guarantee can be given as to the achievement of the sub-fund's investment objective. |
Besonderheiten |
Aktueller Preis * | 115.79 CHF | 11.11.2024 |
---|---|---|
Vorheriger Preis * | 114.70 CHF | 08.11.2024 |
52 Wochen Hoch * | 119.11 CHF | 30.08.2024 |
52 Wochen Tief * | 97.73 CHF | 13.11.2023 |
NAV * | 115.79 CHF | 11.11.2024 |
Ausgabepreis * | ||
Rücknahmepreis * | ||
Schlusskurs * | ||
Indikativer Minimalpreis | ||
Fondsvermögen *** | 12'060'232 | |
Anteilsklassevermögen *** | 377'271 | |
Trading Information SIX |
YTD-Performance | +12.10% |
31.12.2023 - 11.11.2024
31.12.2023 11.11.2024 |
---|---|---|
1 Monat | -0.96% |
11.10.2024 - 11.11.2024
11.10.2024 11.11.2024 |
3 Monate | +1.76% |
12.08.2024 - 11.11.2024
12.08.2024 11.11.2024 |
6 Monate | +2.93% |
13.05.2024 - 11.11.2024
13.05.2024 11.11.2024 |
1 Jahr | +18.48% |
13.11.2023 - 11.11.2024
13.11.2023 11.11.2024 |
2 Jahre | +12.26% |
11.11.2022 - 11.11.2024
11.11.2022 11.11.2024 |
3 Jahre | -11.33% |
11.11.2021 - 11.11.2024
11.11.2021 11.11.2024 |
5 Jahre | +22.94% |
23.04.2020 - 11.11.2024
23.04.2020 11.11.2024 |
Kapitalbeteiligungsquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteil am Gesamtvermögen in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Immobilienquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Roche Holding AG | 11.75% | |
---|---|---|
Nestle SA | 11.42% | |
Novartis AG Registered Shares | 9.15% | |
ABB Ltd | 7.34% | |
UBS Group AG | 5.21% | |
Alcon Inc | 4.00% | |
Zurich Insurance Group AG | 3.39% | |
Lonza Group Ltd | 3.37% | |
Sika AG | 3.15% | |
Accelleron Industries AG Ordinary Shares | 2.61% | |
Letzte Daten-Aktualisierung | 31.07.2024 |
TER | 0.90% |
---|---|
Datum TER | 30.04.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.00% |
Ongoing Charges *** | 1.18% |
SRRI ***
|
|
Datum SRRI *** | 31.10.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |